Summary
The X-gene product of human hepatitis B virus is a transacting transcriptional factor which activates a variety of heterologous viral and host promoters/enhancers. We have found that the X-gene product can significantly transactivate the regulatory sequences located at the 5′-upstream of the c-jun oncogene when a reporter plasmid containing the sequences was co-transfected to HepG2 cells with an X-gene expression plasmid. The results of mutational analysis indicate that the X-gene activation requires the AP-1 sequence of the c-jun gene. Furthermore, we also found that the X-gene is capable of activating the 5′-upstream sequence of the α-fetoprotein gene. There are at least two elements that respond to the X-gene transactivation. One is located in the sequences between −5100 and −2900, and the other is at the C/EBP site. Therefore, the X-gene activates the c-jun and α-fetoprotein genes through different host factors, namely AP-1 and C/EBP, respectively. The results of c-jun activation by the X-gene strongly support the previous hypothesis that the X-gene may play a critical role in the development of hepatocellular carcinoma.
Similar content being viewed by others
References
Angel P, Hattori K, Smeal T, Karin M (1988) The jun protooncogen is positively autoregulated by its product, Jun/AP-1. Cell 55: 875–885
Beasley RP, Hwang LY (1984) In: Vyan GN, Dienstag JL, Hootnagle JH (eds) Viral hepatitis and liver disease. Crune and Stratton, New York, pp 209–224
Chisari FV, Filippi P, McLachlan A, Milich DR, Riggs M (1986) Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol 60: 880–887
Dejean A, Bougueleret L, Grzeschik KH, Tiollais P (1986) Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in hepatocellular carcinoma. Nature 322: 70–72
Fisch TM, Prywes R, Roeder R (1987) c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-0-tetradecanoyl phorbol-13-acetate and the calcium ionophore. Mol Cell Biol 7: 3490–3502
Gorman CM, Moffat L, Howard BH (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044–1051
Groot R, Foulkes N, Mulder M, Kruijer W, Sassocorsi P (1991) Positive regulation of jun/AP-1 by ElA. Mol Cell Biol 11: 192–201
Ganem D, Varmus HE (1987) The moleculer biology of the hepatitis B viruses. Annu Rev Biochem 56: 651–693
Haritani H, Esumi M, Uchida T, Shikata T (1991) Oncogene expression in the liver tissue of patients with nonneoplastic liver disease. Cancer 67: 2594–2598
Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerrlich WH (1990) Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9: 1137–1145
Hollinger FB, Robinson WS, Purcell RH, Gerin JL, Ticehurst J (1990) Viral hepatitis. Raven Press, New York, pp 73–138
Hsu TY, Moroy T, Etiemble J, Louise A, Trepo C, Tiollais P, Buendia MA (1988) Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55: 627–635
Hu KQ, Vierling JM, Siddiqui A (1990) Transactivation of HLA-DR gene by hepatitis B virus X-gene product. Proc Natl Acad Sci USA 87: 7140–7144
Kim CM, Koike K, Saito I, Miyamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317–320
Maguire HF, Hoeffler JP, Siddiqui A (1991) HBV X protein alters the DNA bnding specificity of CREB and ATF-2 protein-protein interactions. Science 252: 842–844
Miyaki M, Sato C, Gotanda T, Matsui T, Mishiro S, Imai M, Mayumi M (1986) Integration of region X of hepatitis B virus genome in human primary hepatocellular carcinomas propagated in nude mice. J Gen Virol 67: 1449–1454
Morello D, Fitzgerald MH, Babinet C, Fausto N (1990) c-myc, c-fos, and c-jun regulation in the regenerating livers of normal and H2K/c-myc transgenic mice. Mol Cell Biol 10: 3185–3193
Moriarty AM, Hoyer BB, Shih JWK, Gerin JL, Hamer DH (1981) Expression of the hepatitis B virus surface antigen gene in cell culture by lusing a simia virus 40 vector. Proc Natl Acad Sci USA 78: 2606–2610
Nagata K, Ohtani K, Nakamura M, Sugamura K (1989) Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40rax protein in the human T-cell line, Jurkat. J Virol 63: 3220–3226
Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K (1987) The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1: 773–782
Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL (1987) Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84: 866–870
Ransone L, Verma M (1990) Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 6: 539–557
Sakai M, Mirinaga T, Urano Y, Watanabe K, Wegmann TG, Tamaoki T (1985) The human alpha-fetoprotein gene. Sequence organization and the 5′ flanking region. J Biol Chem 260: 5055–5060
Schutte J, Minna JD, Birrer MJ (1989) Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-la cells as a single gene. Proc Natl Acad Sci USA 86: 2257–2261
Seto LE, Mitchell PJ, Yen T (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344: 72–74
Seto E, Yen TS, Peterlin BM, Ou JH (1988) Transactivation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 85: 8286–8290
Sherker AH, Marion PL (1991) Hepadenaviruses and hepatocellular carcinoma. Annu Rev Microbiol 45: 475–508
Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K (1989) The X-gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 80: 617–621
Siddiqui A, Gaynor R, Srinivasan A, Maples J, Farr RW (1989) Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology 169: 479–484
Spandau DF, Lee CH (1988) Transactivation of viral enhancers by the hepatitis B virus X protein. J Virol 62: 427–434
Szmuness W, Stevens CE, Keram H, Much M, Harley EJ, Hollinger B (1978) Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans. J Infect Dis 137: 822–829
Twu J, Chu K, Robinson W (1989) Hepatitis B virus X-gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc Natl Acad Sci USA 86: 5168–5172
Twu J, Rosen CA, Haseltine WA, Robinson WS (1989) Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X. J Virol 63: 2857–2860
Twu JS, Shloemer RH (1987) Transcriptional transactivating function of hepatitis B virus. J Virol 61: 3448–3453
Vandeyar M, Weiner M, Hutton C, Batt C (1988) A simple and rapid method for the selection of oligodeoxynucleotide-directed mutants. Gene 65: 129
Zahm PM, Hofshneider PH, Koshy R (1988) The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3: 169–177
Zhang XK, Dong JM, Chiu JF (1990) Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. J Biol Chem 266: 8248–8254
Zhang XK, Huang DP, Chiu DK, Chiu JF (1987) The expression of oncogenes in human developing liver and hepatomas. Biochem Biophys Res Commun 142: 932–938
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhou, M.X., Watabe, M. & Watabe, K. The X-gene of human hepatitis B virus transactivates the c-jun and α-fetoprotein genes. Archives of Virology 134, 369–378 (1994). https://doi.org/10.1007/BF01310574
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01310574